Journals / İstanbul Kuzey Klinikleri / 2019 / Cilt: 6 - Sayı: 4

IL-15 negatively regulates curdlan-induced IL-23 production by human monocyte-derived dendritic cells and subsequent Th17 response

Pages
379–387
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results may explain why IL-15-exposed DCs produce less IL-23after maturation with curdlan, which is a ligand of Dectin-1.CONCLUSION: Short- or long-term exposure to IL-15 of human DCs during their differentiation or maturation programs DCsagainst Th17 cell polarization, which suggests that IL-15 availability may affect CD4+ T cell-mediated protective immunity tofungal infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: In this study, we aimed to assess the effects of long- and short-term IL-15 cytokine exposure of human monocyte-derived curdlan-matured dendritic cells (DCs) on the production of Th17 cell-polarizing cytokine IL-23 and subsequentTh17 cell activation.METHODS: Peripheral blood mononuclear cells (PBMCs) were purified using Ficoll-Paque from healthy donors.
📊
Key Findings & Data:Monocyteswere magnetically selected using CD14 Miltenyi beads and differentiated into DCs with granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 for five days in the presence or absence of IL-15 (100ng/ml) for long-term exposure experiments.
💡
Conclusion & Impact:These results may explain why IL-15-exposed DCs produce less IL-23after maturation with curdlan, which is a ligand of Dectin-1.CONCLUSION: Short- or long-term exposure to IL-15 of human DCs during their differentiation or maturation programs DCsagainst Th17 cell polarization, which suggests that IL-15 availability may affect CD4+ T cell-mediated protective immunity tofungal infections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: In this study, we aimed to assess the effects of long- and short-term IL-15 cytokine exposure of human monocyte-derived curdlan-matured dendritic cells (DCs) on the production of Th17 cell-polarizing cytokine IL-23 and subsequentTh17 cell activation.METHODS: Peripheral blood mononuclear cells (PBMCs) were purified using Ficoll-Paque from healthy donors. Monocyteswere magnetically selected using CD14 Miltenyi beads and differentiated into DCs with granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 for five days in the presence or absence of IL-15 (100ng/ml) for long-term exposure experiments. Then, DCs were matured with peptidoglycan (PGN), or curdlan for 24 hours. For short-term exposure experiments,IL-15 was added only during maturation of DCs. Then, DCs were characterized concerning the expression of MHC II andcostimulatory molecules, production of cytokine subunits IL-23p19, IL-12p40, IL-12p35 and cytokine IL-23 via flow cytometryor real-time qPCR or ELISA. Finally, the phosphorylation of signaling molecules after curdlan stimulation was assessed usingphospho-flow assays.RESULTS: IL-15 exposure suppressed IL-23 production by DCs. As a result, IL-15-exposed DCs suppressed IL-17 productionby allogeneic T cells. Importantly, we observed a reduction in the surface Dectin-1 receptor levels by IL-15-exposed DCs.In line with these observations, curdlan stimulation resulted in reduced phosphorylation of ERK1/2, NF-kB p65 and AKT byhuman DCs exposed to IL-15 compared with controls. These results may explain why IL-15-exposed DCs produce less IL-23after maturation with curdlan, which is a ligand of Dectin-1.CONCLUSION: Short- or long-term exposure to IL-15 of human DCs during their differentiation or maturation programs DCsagainst Th17 cell polarization, which suggests that IL-15 availability may affect CD4+ T cell-mediated protective immunity tofungal infections.

🔖

Cite This Article

HALİLOĞLU, Y., KARAKUKCU, M., OKUS, F. Z., ERDEM, Ş., GÜR, T. N., AZİZOĞLU, Z. B., BİÇER, A., ALTUNTAŞ, H. D., EKEN, A., YILMAZ, E., CANATAN, H. (2022). IL-15 negatively regulates curdlan-induced IL-23 production by human monocyte-derived dendritic cells and subsequent Th17 response. İstanbul Kuzey Klinikleri, Cilt: 6 - Sayı: 4, 379–387. https://ajindex.com/articles/652030

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Waldmann TA. Interleukin-15 in the treatment of cancer. Expert Rev Clin Immunol 2014;10:1689–701. [CrossRef ] 2. Waldmann TA. The Biology of IL-15: Implications for Cancer Therapy and the Treatment of Autoimmune Disorders. J Investig Dermatology Symp Proc 2013;16:S28–30. [CrossRef ] 3. Croce M, Orengo AM, Azzarone B, Ferrini S. Immunotherapeutic applications of IL-15. Immunotherapy 2012;4:957–69. [CrossRef ] 4. Grabstein K, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264:965–8. [CrossRef ] 5. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994;91:4935–9. [CrossRef ] 6. Bamford RN, Battiata AP, Burton JD, Sharma H, Waldmann TA. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci U S A 1996;93:2897–902. [CrossRef ] 7. Waickman AT, Ligons DL, Hwang S, Park JY, Lazarevic V, Sato N, et al. CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans. Cytokine 2017;99:266–74. [CrossRef ] 8. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995;14:3654–63. [CrossRef ] 9. Spolski R, Gromer D, Leonard WJ. The γc family of cytokines: finetuning signals from IL-2 and IL-21 in the regulation of the immune response. F1000Res 2017;6:1872. [CrossRef ] 10. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells. Immunity 2002;17:537– 47. [CrossRef ] 11. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998;8:591–9. [CrossRef ] 12. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395–403. [Cross